The emerging roles of PAF acetylhydrolase

Journal of Lipid Research

Volumn 50, Issue SUPPL., 2009, Pages

  McIntyre, Thomas M ^a   Prescott, Stephen M ^b   Stafforini, Diana M ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Lp PLA2; Oxidized phospholipids; Platelet activating factor

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL; APOPTOSIS; ARTICLE; ENZYME SPECIFICITY; HUMAN; INFLAMMATION; METABOLISM;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANIMALS; APOPTOSIS; HUMANS; INFLAMMATION; METABOLISM; PLATELET ACTIVATING FACTOR; SUBSTRATE SPECIFICITY;

EID: 84863471476     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R800024-JLR200     Document Type: Review

References (50)

1. Ishii, S., T. Nagase, and T. Shimizu. 2002. Platelet-activating factor receptor. Prostagland Other Lipid Mediators. 68-69: 599-609. (Pubitemid 35247423)
2. Prescott, S.M., G.A. Zimmerman,D. M. Stafforini, and T. M. McIntyre. 2000. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69: 419-445.
3. Six, D. A., and E. A. Dennis. 2000. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta. 1488: 1-19.
4. Tjoelker, L.W., C. Eberhardt, J. Unger, H. L. Trong, G. A. Zimmerman, T. M. McIntyre, D. M. Stafforini, S. M. Prescott, and P. W. Gray. 1995. Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J. Biol. Chem. 270: 25481-25487.
5. Samanta, U., and B. J. Bahnson. 2008. Crystal structure of human plasma platelet activating factor acetylhydrolase; structural implication to lipoprotein binding and catalysis. J. Biol. Chem. In press.
6. Arai, H., H. Koizumi, J. Aoki, and K. Inoue. 2002. Platelet-activating factor acetylhydrolase (PAF-AH). J. Biochem. (Tokyo). 131: 635-640. (Pubitemid 34535029)
7. Hattori, K., H. Adachi, A. Matsuzawa, K. Yamamoto, M. Tsujimoto, J. Aoki, M. Hattori, H. Arai, and K. Inoue. 1996. cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolase. J. Biol. Chem. 271: 33032-33038.
8. Kono, N., T. Inoue, Y. Yoshida, H. Sato, T. Matsusue, H. Itabe, E. Niki, J. Aoki, and H. Arai. 2008. Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo. J. Biol. Chem. 283: 1628-1636.
9. Elstad, M. R., D. M. Stafforini, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 1989. Platelet-activating factor acetylhydrolase increases during macrophage differentiation: a novel mechanism that regulates accumulation of platelet-activating factor. J. Biol. Chem. 264: 8467-8470. (Pubitemid 19151553)
10. Asano, K., S. Okamoto, K. Fukunaga, T. Shiomi, T. Mori, M. Iwata, Y. Ikeda, and K. Yamaguchi. 1999. Cellular source(s) of platelet-activating- factor acetylhydrolase activity in plasma. Biochem. Biophys. Res. Commun. 261: 511-514. (Pubitemid 29392507)
11. Stafforini, D.M., K. Satoh, D.L. Atkinson, L. W. Tjoelker, C. Eberhardt, H. Yoshida, T-a. Imaizumi, S. Takamatsu, G. A. Zimmerman, T. M. McIntyre, et al. 1996. Platelet-activating factor acetylhydrolase deficiency: a missense mutation near the active site of an anti-inflammatory phospholipase. J. Clin. Invest. 97: 2784-2791. (Pubitemid 26197091)
12. Stafforini, D. M., T. M. McIntyre, M. E. Carter, and S. M. Prescott. 1987. Human plasma platelet-activating factor acetylhydrolase: association with lipoprotein particles and role in the degradation of platelet-activating factor. J. Biol. Chem. 262: 4215-4222. (Pubitemid 17102639)
13. Stafforini, D. M. 2009. Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2). Cardiovasc. Drugs Ther. 23: 73-83.
14. Matsuzawa, A., K. Hattori, J. Aoki, H. Arai, and K. Inoue. 1997. Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II. J. Biol. Chem. 272:32315-32320. (Pubitemid 28011912)
15. Ho, Y. S., P. J. Sheffield, J. Masuyama, H. Arai, J. Li, J. Aoki, K. Inoue, U. Derewenda, and Z. S. Derewenda. 1999. Probing the substrate specificity of the intracellular brain platelet-activating factor acetylhydrolase. Protein Eng. 12: 693-700. (Pubitemid 29425555)
16. Stremler, K. E., D. M. Stafforini, S. M. Prescott, and T. M. McIntyre. 1991. Human plasma platelet-activating factor acetylhydrolase: oxidatively-fragmented phospholipids as substrates. J. Biol. Chem. 266: 11095-11103. (Pubitemid 21906916)
17. Kriska, T., G. K. Marathe, J. C. Schmidt, T. M. McIntyre, and A. W. Girotti. 2007. Phospholipase action of platelet-activating factor acetylhydrolase, but not paraoxonase-1, on long fatty acyl chain phospholipid hydroperoxides. J. Biol. Chem. 282: 100-108. (Pubitemid 47076629)
18. Stafforini, D. M., J. R. Sheller, T. S. Blackwell, A. Sapirstein, F. E. Yull, T. M. McIntyre, J. V. Bonventre, S. M. Prescott, and L. J. Roberts 2nd. 2006. Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J. Biol. Chem. 281: 4616-4623. (Pubitemid 43847720)
19. Davis, B., G. Koster, L. J. Douet, M. Scigelova, G. Woffendin, J. M. Ward, A. Smith, J. Humphries, K. G. Burnand, C. H. Macphee, et al. 2007. Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein. J. Biol. Chem. 283: 6428-6437.
20. Tjoelker, L. W., C. Wilder, C. Eberhardt, D. M. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H. Le Trong, L. S. Cousens, G. A. Zimmerman, et al. 1995. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature. 374: 549-553.
21. Fukuda, Y., H. Kawashima, K. Saito, N. Inomata, M. Matsui, and T. Nakanishi. 2000. Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models. Eur. J. Pharmacol. 390: 203-207. (Pubitemid 30122455)
22. Vadas, P., M. Gold, B. Perelman, G. M. Liss, G. Lack, T. Blyth, F. E. Simons, K. J. Simons, D. Cass, and J. Yeung. 2008. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N. Engl. J. Med. 358: 28-35.
23. Henson, P. M., and R. N. Pinckard. 1977. Platelet activating factor (PAF). A possible direct mediator of anaphylaxis in the rabbit and a trigger for the vascular deposition of circulating immune complexes. Monogr. Allergy. 12: 13-26.
24. Gomes, R. N., F. A. Bozza, R. T. Amancio, A. M. Japiassu, R. C. Vianna, A. P. Larangeira, J. M. Gouvea, M. S. Bastos, G. A. Zimmerman, D. M. Stafforini, et al. 2006. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock. 26: 41-49. (Pubitemid 44297005)
25. Caplan, M. S., M. Lickerman, L. Adler, G. N. Dietsch, and A. Yu. 1997. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr. Res. 42: 779-783. (Pubitemid 27509535)
26. Hofbauer, B., A. K. Saluja, M. Bhatia, J. L. Frossard, H. S. Lee, L. Bhagat, and M. L. Steer. 1998. Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. Gastroenterol. 115: 1238-1247. (Pubitemid 28485616)
27. Bedirli, A., S. Gokahmetoglu, O. Sakrak, I. Soyuer, O. Ince, and E. Sozuer. 2004. Beneficial effects of recombinant platelet-activating factor acetylhydrolase and BN 52021 on bacterial translocation in cerulein-induced pancreatitis. Eur. Surg. Res. Europaische chirurgische. Forschung. 36: 136-141. (Pubitemid 38621567)
28. Grypioti, A. D., G. Kostopanagiotou, and M. Mykoniatis. 2007. Platelet-activating factor inactivator (rPAF-AH) enhances liver's recovery after paracetamol intoxication. Dig. Dis. Sci. 52: 2580-2590. (Pubitemid 47373912)
29. Lee, E. S., J. Jiang, G. C. Sund, W. T. Simonson, J. Graham, G. Dietsch, B. Schimpf, S. Bieg, G. Peterman, and A. Lernmark. 1999. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat. Diabetes. 48: 43-49. (Pubitemid 29019351)
30. Theilmeier, G., B. De Geest, P. P. Van Veldhoven, D. Stengel, C. Michiels, M. Lox, M. Landeloos, M. J. Chapman, E. Ninio, D. Collen, et al. 2000. HDL-associated PAF-AH reduces endothelial adhesiveness in apoE2/2 mice. FASEB J. 14: 2032-2039.
31. Quarck, R., B. De Geest, D. Stengel, A. Mertens, M. Lox, G. Theilmeier, C. Michiels, M. Raes, H. Bult, D. Collen, et al. 2001. Adenovirus-mediated gene transfer of human platelet-activating factor- acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice. Circulation. 103: 2495-2500. (Pubitemid 32493377)
32. Hase, M., M. Tanaka, M. Yokota, and Y. Yamada. 2002. Reduction in the extent of atherosclerosis in apolipoprotein E-deficient mice induced by electroporation-mediated transfer of the human plasma platelet-activating factor acetylhydrolase gene into skeletal muscle. Prostagland. Other Lipid Mediators. 70: 107-118.
33. Noto, H., M. Hara, K. Karasawa, O. N. Iso, H. Satoh, M. Togo, Y. Hashimoto, Y. Yamada, T. Kosaka, M. Kawamura, et al. 2003. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress. Arterioscler. Thromb. Vasc. Biol. 23: 829-835. (Pubitemid 36566173)
34. Turunen, P., J. Jalkanen, T. Heikura, H. Puhakka, J. Karppi, K. Nyyssonen, and S. Yla-Herttuala. 2004. Adenovirus-mediated gene transfer of Lp-PLA2 reduces LDL degradation and foam cell formation in vitro. J. Lipid Res. 45: 1633-1639. (Pubitemid 39296202)
35. Letters, J. M., P. K. Witting, J. K. Christison, A. W. Eriksson, K. Pettersson, and R. Stocker. 1999. Time-dependent changes to lipids and antioxidants in plasma and aortas of apolipoprotein E knockout mice. J. Lipid Res. 40: 1104-1112. (Pubitemid 29287881)
36. Heinecke, J. W. 1987. Free radical modification of low-density lipoprotein: mechanisms and biological consequences. Free Radic. Biol. Med. 3: 65-73.
37. Marathe, G. K., S. S. Davies, K. A. Harrison, A. R. Silva, R. C. Murphy, H. Castro-Faria Neto, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 1999. Inflammatory PAF-like lipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J. Biol. Chem. 274: 28395-28405.
38. Chen, R., L. Yang, and T. M. McIntyre. 2007. Cytotoxic phospholipid oxidation products: cell death from mitochondrial damage and the intrinsic caspase cascade. J. Biol. Chem. 282: 24842-24850. (Pubitemid 47347534)
39. Podrez, E. A., E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P. J. Finton, L. Shan, B. Gugiu, P. L. Fox, et al. 2002. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J. Biol. Chem. 277:38503-38516. (Pubitemid 35154709)
40. Subbanagounder, G., N. Leitinger, D. C. Schwenke, J. W. Wong, H. Lee, C. Rizza, A. D. Watson, K. F. Faull, A. M. Fogelman, and J. A. Berliner. 2000. Determinants of bioactivity of oxidized phospholipids: specific oxidized fatty acyl groups at the sn-2 position. Arterioscler. Thromb. Vasc. Biol. 20: 2248-2254.
41. Serruys, P. W., H. M. Garcia-Garcia, P. Buszman, P. Erne, S. Verheye, M. Aschermann, H. Duckers, O. Bleie, D. Dudek, H. E. Botker, et al. 2008. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation. 118: 1172-1182.
42. Bonin, F., S. D. Ryan, L. Migahed, F. Mo, J. Lallier, D. J. Franks, H. Arai, and S. A. Bennett. 2004. Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I {alpha}2 catalytic subunit. J. Biol. Chem. 279: 52425-52436. (Pubitemid 39656619)
43. Ogden, F., M. A. DeCoster, and N. G. Bazan. 1998. Recombinant plasma-type platelet-activating factor acetylhydrolase attenuates NMDA-induced hippocampal neuronal apoptosis. J. Neurosci. Res. 53: 677-684. (Pubitemid 28423876)
44. Hirashima, Y., H. Ueno, K. Karasawa, K. Yokoyama, M. Setaka, and A. Takaku. 2000. Transfection of the plasma-type platelet-activating factor acetylhydrolase gene attenuates glutamate-induced apoptosis in cultured rat cortical neurons. Brain Res. 885: 128-132.
45. Kuijpers, T. W., J. M. van den Berg, A. T. Tool, and D. Roos. 2001. The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase. Clin. Exp. Immunol. 123: 412-420. (Pubitemid 32289960)
46. Marques, M., Y. Pei, M. D. Southall, J. M. Johnston, H. Arai, J. Aoki, T. Inoue, H. Seltmann, C. C. Zouboulis, and J. B. Travers. 2002. Identification of platelet-activating factor acetylhydrolase II in human skin. J. Invest. Dermatol. 119: 913-919. (Pubitemid 35340918)
47. Foulks, J. M., A. S. Weyrich, G. A. Zimmerman, and T. M. McIntyre. 2008. A yeast PAF acetylhydrolase ortholog suppresses oxidative death. Free Radic. Biol. Med. 45: 434-442.
48. Chen, J., L. Yang, J. M. Foulks, A. S.Weyrich, G. K. Marathe, and T. M. McIntyre. 2007. Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis. J. Lipid Res. 48: 2365-2376. (Pubitemid 350058748)
49. Reinhold, S. L., G. A. Zimmerman, S. M. Prescott, and T. M. McIntyre. 1989. Phospholipid remodeling in human neutrophils. Parallel activation of a deacylation/reacylation cycle and platelet-activating factor synthesis. J. Biol. Chem. 264: 21652-21659. (Pubitemid 20028732)
50. Garza, C. A., V. M. Montori, J. P. McConnell, V. K. Somers, I. J. Kullo, and F. Lopez-Jimenez. 2007. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin. Proc. 82: 159-165. (Pubitemid 46198473)